Clinical Trial Update: Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial reporting safety and efficacy data for APD811 in pulmonary arterial hypertension has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• APD811

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2020-07-14